Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Efficacy, & Use of ViviGen Cellular Bone Matrix Allograft in Orthopaedic Fracture Care: A Multi-Center Prospective Registry and Retrospective Data Collection Study

NCT04299022 is registered in ClinicalTrials.gov with LifeNet Health as lead sponsor.

NCT NCT04299022
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04299022 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Efficacy, & Use of ViviGen Cellular Bone Matrix Allograft in Orthopaedic Fracture Care: A Multi-Center Prospective Registry and Retrospective Data Collection Study
Lead sponsor
LifeNet Health
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2021
Completion date
July 31, 2028
Enrollment
250 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

fracture arm, fracture of femur, fracture, tibial, fractures, bone, fractures, open, fractures, ununited, nonunion of fracture